Australia is closely awaiting the arrival of retatrutide, a innovative dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, this https://sidneyslis343043.wikimillions.com/583568/retatrutide_australia_a_potential_breakthrough_for_weight_management